HR1990-119

In Committee

American Innovation and R&D Competitiveness Act of 2025

119th Congress Introduced Mar 10, 2025

Summary

What This Bill Does

The American Innovation and R&D Competitiveness Act reverses the mandatory capitalization approach for research and experimental expenditures. It rewrites Internal Revenue Code section 174 so taxpayers may treat qualifying research or experimental costs paid or incurred in a trade or business as deductible expenses rather than capital account charges. Taxpayers can adopt the expense method without consent for their first eligible year or later with Treasury consent, and they can still elect to amortize capitalized research expenses over at least 60 months. The bill keeps exclusions for land, depreciable or depletable property acquisition or improvement, mineral exploration, and unreasonable amounts. It also updates section 41 and section 280C coordination rules for the research credit, including reduced-credit elections, and makes the amendments apply to taxable years beginning after December 31, 2021.

Who Benefits and How

Research-intensive businesses benefit because domestic R&D costs can be deducted immediately instead of recovered over time. Startups and small technology firms benefit from improved cash flow when early research spending reduces taxable income sooner. Manufacturers with product-development programs benefit because engineering and experimentation costs receive more favorable timing. Tax accountants and corporate tax departments benefit from clearer coordination between section 174 deductions and section 41 research credits.

Who Bears the Burden and How

The Treasury Department and IRS must administer retroactive section 174 changes, method elections, and research-credit coordination rules. Federal taxpayers bear revenue loss if accelerated deductions reduce business tax collections. Businesses claiming the benefit must document reasonable research expenditures and apply exclusions for land, property, and mineral exploration. IRS examiners must review deduction timing, amortization elections, and reduced-credit elections for affected taxable years.

Key Provisions

  • Amends section 174 to allow immediate deductions for qualifying research and experimental expenditures.
  • Provides an elective amortization method over at least 60 months for capitalized research expenses.
  • Limits eligibility for land, depreciable or depletable property, mineral exploration, and unreasonable expenditures.
  • Modifies section 41 and section 280C research-credit coordination and applies the changes after December 31, 2021.

Evidence Chain:

This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers with clause-level evidence links.

At a Glance

What This Bill Does

Restores immediate deduction treatment for business research and experimental expenditures under section 174, preserves elective amortization, coordinates the research credit deduction disallowance, and applies the changes to taxable years after 2021.

Key Policy Areas

Tax, Research and Development, Business

Primary Purpose

Restores immediate deduction treatment for business research and experimental expenditures under section 174, preserves elective amortization, coordinates the research credit deduction disallowance, and applies the changes to taxable years after 2021.

Policy Domains

Tax Research and Development Business

Resolution provisions

Identified Gains
  • Research-intensive businesses
  • Startups
  • Manufacturers with product-development programs
  • Corporate tax departments
Model: codex-gpt-5 | Version: bill_summary_v2 | Source: ih
Startups: ,
Corporate tax departments: ,
Research-intensive businesses: ,
Manufacturers with product-development programs: ,
Identified Costs
  • Treasury Department
  • Federal taxpayers
  • Businesses claiming research deductions
  • IRS examiners
Model: codex-gpt-5 | Version: bill_summary_v2 | Source: ih
IRS examiners: ,
Federal taxpayers: ,
Treasury Department: ,
Businesses claiming research deductions: ,

Legislative Progress

In Committee
Introduced Committee Passed
Mar 10, 2025

Mr. Estes (for himself, Mr. Larson of Connecticut, Mr. Buchanan, …

Mar 10, 2025

Referred to the House Committee on Ways and Means.

Mar 10, 2025

Introduced in House

Stakeholder Effects

cui bono?

How this legislation distributes effects. Mention counts reflect frequency, not effect magnitude.

Small Business
2 mentions across 2 clauses
+2 positive

Research-intensive businesses

Technology
2 mentions across 2 clauses
+2 positive

Startups

Manufacturing
2 mentions across 2 clauses
+2 positive

Manufacturers with product-development programs

Government
2 mentions across 2 clauses
-2 negative

Treasury Department

Taxpayers
2 mentions across 2 clauses
-2 negative

Taxpayers

Government Employees
2 mentions across 2 clauses
-2 negative

IRS examiners

2/3
sections analyzed
Full impact breakdown

Bill Structure & Actor Mappings

Who is "The Secretary" in each section?

Domains
Tax Research and Development Business

We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.

Learn more about our methodology